TWST
Twist Bioscience·NASDAQ
--
--(--)
--
--(--)
TWST fundamentals
Twist Bioscience (TWST) Revenue Breakdown: Q1 2026 Business & Regional Performance
Twist Bioscience (TWST) reported total revenue of 103.70M USD in Q1 2026, with its core business segment Therapeutics contributing 35.90%. Regionally, Americas remained the largest market, accounting for 56.30% of total revenue. Explore Twist Bioscience's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Twist Bioscience (TWST) reported total revenue of 103.70M USD in Q1 2026, with its core business segment Therapeutics contributing 35.90%. Regionally, Americas remained the largest market, accounting for 56.30% of total revenue. Explore Twist Bioscience's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What guidance did Twist Bioscience's management provide for the next earnings period?What is Twist Bioscience's latest dividend and current dividend yield?What factors drove the changes in Twist Bioscience's revenue and profit?What were the key takeaways from Twist Bioscience's earnings call?What is the market's earnings forecast for Twist Bioscience next quarter?What were the key takeaways from Twist Bioscience’s earnings call?Did Twist Bioscience beat or miss consensus estimates last quarter?What does Twist Bioscience do and what are its main business segments?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
